A generic alternative indicated for Neurology. This medication supports cognitive function and assists in managing the underlying cellular processes observed in neurodegenerative pathways.
Utilized to manage moderate to severe Alzheimer's by addressing abnormal glutamate activity to support memory retention and alleviate the decline of daily functioning.
Mechanism of Action
Memantine blocks specific receptors in the brain that are overstimulated by glutamate. In Alzheimer's, too much glutamate damages nerve cells; memantine regulates this activity to protect neurons and improve signaling.
Route of Administration
Oral
Onset Time
Steady state in 2 weeks
Duration
12–24 hours
Contraindications
Severe kidney impairment, Hypersensitivity to memantine
Information for Memantine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
